Belgian-Dutch pharma company Argenx SE said Monday that it has agreed to acquire Forte Biosciences Inc. for approximately $2.2 billion, building on its existing investment in the U.S. company.
Belgian-Dutch pharma company Argenx SE said Monday that it has agreed to acquire Forte Biosciences Inc. for approximately $2.2 billion, building on its existing investment in the U.S. company.
DCC Energy PLC said Monday that it is backing an offer worth up to £5.75 billion ($7.7 billion) from KKR and Energy Capital Partners, making it the latest London-listed company targeted in a take-private deal by U.S. buyers.
IP Group said Monday that it will press ahead with its existing strategy after the company's largest shareholder, a U.K. retirement savings plan for railway staff, formally withdrew from a possible takeover.
Serica Energy said Monday that it will acquire its rival oil producer Pharos Energy for approximately £145.7 million ($193.85 million) in a deal that will expand its footprint to Asia and Africa.
Trustees of U.K. defined benefit schemes should not view the completion of a pension buy-in as the end of their long-term plans, a retirement saving specialist warned Monday.
Scancell said Monday that it has raised £2.7 million ($4 million) from retail investors, taking the total amount secured through that share sale and a separate placing to £15.7 million.
Chemicals manufacturer Johnson Matthey confirmed Monday that it plans to return around £1 billion ($1.3 billion) to shareholders now that the £1.33 billion sale of its Catalyst Technologies business to U.S. tech company Honeywell is complete.
